SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15082483
Source:
http://linkedlifedata.com/resource/pubmed/id/15082483
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013331
,
umls-concept:C0021469
,
umls-concept:C0030705
,
umls-concept:C0038013
,
umls-concept:C0038951
,
umls-concept:C0087111
,
umls-concept:C0332293
,
umls-concept:C0334889
,
umls-concept:C1456820
pubmed:issue
5
pubmed:dateCreated
2004-4-14
pubmed:abstractText
To determine the criteria considered important by Dutch rheumatologists in judging whether a patient with ankylosing spondylitis should start tumour necrosis factor (TNF) blocking therapy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15082483-10229426
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15082483-10229428
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15082483-10229432
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15082483-11455853
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15082483-11642642
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15082483-11955536
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15082483-11986408
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15082483-12381508
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0003-4967
pubmed:author
pubmed-author:LandewéRR
,
pubmed-author:RumpBB
,
pubmed-author:van der HeijdeDD
,
pubmed-author:van der LindenSS
pubmed:issnType
Print
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
530-4
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:15082483-Attitude of Health Personnel
,
pubmed-meshheading:15082483-Cohort Studies
,
pubmed-meshheading:15082483-Female
,
pubmed-meshheading:15082483-Health Priorities
,
pubmed-meshheading:15082483-Humans
,
pubmed-meshheading:15082483-Judgment
,
pubmed-meshheading:15082483-Male
,
pubmed-meshheading:15082483-Middle Aged
,
pubmed-meshheading:15082483-Professional Practice
,
pubmed-meshheading:15082483-Rheumatology
,
pubmed-meshheading:15082483-Spondylitis, Ankylosing
,
pubmed-meshheading:15082483-Tumor Necrosis Factor-alpha
pubmed:year
2004
pubmed:articleTitle
Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists.
pubmed:affiliation
University Hospital Maastricht, Department of Internal Medicine/Rheumatology, Maastricht, Netherlands. rlan@sint.azm.nl
pubmed:publicationType
Journal Article